Optimizing DMPK Properties: Experiences from a Big Pharma DMPK Department

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|17|3|253-270

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.17, Iss.3, 2016-03, pp. : 253-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery DMPK: changing paradigms in the eighties, nineties and noughties

By Summerfield Scott   Jeffrey Phil  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 3, 2009-03 ,pp. : 207-218

Informa Healthcare

Access to resources Recommend Favorite

The Influence of DMPK as an Integrated Partner i n Mod ern Drug Discovery

By  

Current Drug Metabolism, Vol. 3, Iss. 5, 2002-10 ,pp. : 527-550

Bentham Science Publishers

Access to resources Recommend Favorite

Optimisation of DMPK by the Inhaled Route: Challenges and Approaches

By  

Current Drug Metabolism, Vol. 13, Iss. 4, 2012-01 ,pp. : 457-473

Bentham Science Publishers

Access to resources Recommend Favorite

The right compound in the right assay at the right time: an integrated discovery DMPK strategy

By Ballard Peter   Brassil Patrick   Bui Khanh H.   Dolgos Hugues   Petersson Carl   Tunek Anders   Webborn Peter J. H.  

Drug Metabolism Reviews, Vol. 44, Iss. 3, 2012-08 ,pp. : 224-252

Informa Healthcare

Access to resources Recommend Favorite

Conflict-of-interest policies protect docs from big pharma influence

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 671, 2013-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite